The c-erbAα protooncogene induces apoptosis in glial cells via a protein kinase C- and bcl-2-suppressible mechanism

Journal of Neurochemistry

Volumn 70, Issue 6, 1998, Pages 2315-2326

  Llanos, Susana ^a   Caelles, Carme ^a   Azorín, Inmaculada ^b   Renau Piqueras, Jaime ^b   Fernández Luna, José L ^c   Boscá, Lisardo ^a   Muñoz, Alberto ^a,d  

^a CSIC   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

Apoptosis; Bcl 2; erbA protooncogene; Glial cells; Protein kinase C

Indexed keywords

LIOTHYRONINE RECEPTOR; PROTEIN KINASE C;

ANIMAL CELL; APOPTOSIS; ARTICLE; ENZYME ACTIVATION; GLIA CELL; NONHUMAN; ONCOGENE C ERB; PRIORITY JOURNAL; PROTO ONCOGENE; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0031744942     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70062315.x     Document Type: Article

References (61)

1. Aizenman Y. and de Vellis J. (1987) Synergistic action of thyroid hormone, insulin and hydrocortisone on astrocyte differentiation. Brain Res. 414, 301-308.
2. Baas D., Bourbeau D., Carre J. L., Sarliéve L. L., Dussault J. H., and Puymirat J. (1994) Expression of α and β thyroid receptors during oligodendrocyte differentiation. Neuroreport 5, 1805-1808.
3. Barres B. A. and Raff M. C. (1994) Control of oligodendrocyte number in the developing rat optic nerve. Neuron 12, 935-942.
4. Barres B. A., Hart I. K., Coles H. S. R., Burne J. F., Voyvodic J. T., Richardson W. D., and Raff M. C. (1992) Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70, 31-46.
5. Barres B. A., Lazar M. A., and Raff M. C. (1994) A novel role for thyroid hormone glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120, 1097-1108.
6. Behrens M., Martinez J. L., Moratilla C., and Renart J. (1995) Apoptosis induced by protein kinase C inhibition in a neuroblastoma cell line. Cell Growth Differ. 6, 1375-1385.
7. Borde I., Evrard C., Galiana E,. and Rouget P. (1995) A permanent glial precursor cell line, immortalized with the adenovirus E1A gene, undergoes apoptosis in restrictive growth conditions. Biochem. Biophys. Res. Commun. 207, 630-635.
8. Bottenstein J.E. and Sato G. H. (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA 76, 514-517.
9. Caelles C., González-Sancho J. M., and Muñoz A. (1997) Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev. 11, 3351-3364.
10. Carlson D. J., Strait K., Schwartz H. L., and Oppenheimer J. H. (1994) Immunofluorescent localization of thyroid hormone receptor isoforms in glial cells of rat brain. Endocrinology 135, 1831-1836.
11. Chen J. D. and Evans R. M. (1995) A transcriptional co-repressor that acts with nuclear hormone receptors. Nature 377, 454-457.
12. Clarke P. G. H. (1990) Developmental cell death: morphological diversity and multiple mechanisms. Anal. Embryol. 181, 195-213.
13. Crespo P., Xu N., Simonds W. F., and Gutkind J. S. (1994) Ras dependent activation of MAP kinase pathway mediated by G-protein βγ subunits. Nature 369, 418-420.
14. Deiss L. P., Galinka H., Berissi H., Cohen O., and Kimchi A. (1996) Cathepsin D protease mediates programmed cell death induced by interferon-γ, Fas/APO-1 and TNF-α. EMBO J. 15, 3861-3870.
15. del Peso L., González-García M., Page C., Herrera R., and Nuñez G. (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-689.
16. Downes M., Carozzi A. J., and Muscat G. E. O. (1995) Constitutive expression of the orphan receptor, Rev-erbAα inhibits muscle differentiation and abrogates the expression of the myoD gene family. Mol. Endocrinol. 9, 1666-1678.
17. Dussault J. H. and Ruel J. (1987) Thyroid hormones and brain development. Annu. Rev. Physiol. 49, 321-334.
18. Forman B. M., Yang C.-R., Stanley F., Casanova J., and Samuels H. H. (1992) c-erbA proto-oncogenes mediate thyroid hormone-dependent and independent regulation of the rat growth hormone and prolactin genes. Mol. Endocrinol. 2, 902-911.
19. 3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis of differentiation and are antagonized by the v-erbA oncogene. Oncogene 9, 749-758.
20. Gilles R. J., Didier N., and Denton M. (1986) Determination of cell number in monolayer cultures. Anal. Biochem. 156, 109-113.
21. Helmer E. R., Raaka B. M., and Samuels H. H. (1996) Hormone-dependent and -independent transcriptional activation by thyroid hormone receptors are mediated by different mechanisms. Endocrinology 137, 390-399.
22. Hibi M., Anning L., Smeal T., Minden A., and Karin M. (1993) Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-jun activation domain. Genes Dev. 7, 2135-2148.
23. Hörlein A. J., Näär A. M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Söderström M., Glass C. K., and Rosenfeld M. G. (1995) Ligand-independent repression by the thyroid hormone is mediated by nuclear receptor co-repressor. Nature 377, 397-404.
24. Iglesias T., Llanos S., López-Barahona M., Pérez-Aranda A., Rodríguez-Peña A., Bernai J., Höhne A., Seliger B., and Muñoz A. (1994) c-erbA and v-erbA modulate growth and gene expression of a mouse glial precursor cell line. Cell Growth Differ. 5, 697-704.
25. Iglesias T., Llanos S., López-Barahona M., Seliger B., Rodíguez-Peña A., Bernal J., and Muñoz A. (1995) Induction of platelet-derived growth factor B/c-sis by the v-erbA oncogene in glial cells. Oncogene 10, 1103-1110.
26. Ikemoto H., Tani E., Matsumoto T., Nakano A., and Furuyama J. (1995) Apoptosis of human glioma cells in response to calphostin C, a specific-protein kinase C inhibitor. J. Neurosurg. 83, 1008-1016.
27. Illera V. A., Perandones C. E., Stunz L. L., Mover D. A. Jr., and Ashman R. F. (1993) Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J. Immunol. 151, 2965-2973.
28. Jacobson M. D. (1997) Bcl-2-related proteins get connected. Curr. Biol. 7, R277-R281.
29. Junco M., Webster C., Crawford C, Boscá L., and Parker P. J. (1994) Protein kinase C V3 domain mutants with differential sensitivities to m-calpain are not resistant to phorbol-ester-induced down-regulation. Eur. J. Biochem. 223, 259-263.
30. Krueger B. K., Burne J. F., and Raff M. C. (1995) Evidence for a large-scale astrocyte death in the developing cerebellum. J. Neurosci. 15, 3366-3374.
31. Lazar M. A. (1993) Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr. Rev. 14, 184-193.
32. Lin A., Frost J., Deng T., Smeal T., Al-Alawi N., Kikkawa U., Hunter T., Brenner D., and Karin M. (1992) Casein kinase II is a negative regulator of c-jun DNA binding and AP-1 activity. Cell 70, 777-789.
33. Llanos S., Iglesias T., Riese H. H., Garrido T., Caelles C., and Muñoz A. (1996) v-erbA oncogene induces invasiveness and anchor-age-independent growth in cultured glial cells by mechanisms involving platelet-derived growth factor. Cell Growth Differ. 7, 373-382.
34. Lotem J. and Sachs L. (1996) Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents. Proc. Natl. Acad. Sci. USA 93, 12507-12512.
35. Lucas M., Sánchez-Margalet V., Sanz A., and Solano F. (1994) Protein kinase C activation promotes cell survival in mature lymphocytes prone to apoptosis. Biochem. Pharmacol. 47, 667-672.
36. 3 receptors in primary cultured astrocytes and neurons. Brain Res. 381, 275-280.
37. Mellon P. L., Windle J. J., Goldsmith P. C., Padula C. A., Roberts J. L., and Weiner R. (1990) Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. I. Neuron 5, 1-10.
38. Muñoz A., Rodríguez-Peña A., Pérez-Castillo A., Ferreiro B., Sutcliffe J. G., and Bernal J. (1991) Effects of neonatal hypothyroidism on rat brain gene expression. Mol. Endocrinol. 5, 273-280.
39. Muñoz A., Wrighton C., Seliger B., Bernal J., and Beug H. (1993) Thyroid hormone receptor/c-erbA: control of commitment and differentiation in the neuronal/chromaffin progenitor line PC12. J. Cell Biol. 121, 423-438.
40. Neveu I. and Ernest A. (1996) Neurotrophins promote the survival of neurons in the cerebellum of hypothyroid rats in vivo. J. Cell Biol. 133, 631-646.
41. Pech M., Rao D., Robbins K. C. and Aaronson S. A. (1989) Functional identification of regulatory elements within the promoter region of platelet-derived growth factor 2. Mol. Cell. Biol. 6, 396-405.
42. Pfahl M. (1993) Nuclear receptor/AP-1 interaction. Endocr. Rev. 14, 651-658.
43. Porter A. G., Ng P., and Jänicke R. U. (1997) Death substrates come alive. Bioessays 19, 501-507.
44. Press R. D., Misra A., Gillaspy G., Samols D., and Goldthwait D. A. (1989) Control expression of c-sis mRNA in human glioblastoma cells by phorbol ester and transforming growth factor β. Cancer Res. 49, 2914-2920.
45. Rami A. and Rabié A. (1988) Effect of thyroid deficiency on the development of glia and hippocampal formation of the rat: an immunocytochemical study. Glia 1, 337-345.
46. Reed J. C. (1994) Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124, 1-6.
47. Reed J. C. (1997) Double identity for proteins of the Bcl-2 family. Nature 387, 773-776.
48. Sambrook J., Fritsch E. F., and Maniatis T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edit. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
49. Sap J., Muñoz A., Damm K., Goldberg Y., Ghysdael J., Leutz A., Beug H., and Vennström B. (1986) The c-erbA protein is a high affinity receptor for thyroid hormone. Nature 324, 635-640.
50. Sarlieve L. L., Bouchon R., Koehl C., and Neskovic N. M. (1983) Cerebroside and sulfatide biosynthesis in the brain of Snell dwarf mouse: effects of thyroxine and growth hormone in the early postnatal period. J. Neurochem. 40, 1058-1062.
51. Schreiber E., Matthias P., Muller M. M., and Schaffner W. (1989) Rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells. Nucleic Acids Res. 17, 6419.
52. Silva M., Grillot D., Benito A., Richard C., Nuñez G., and Fernández-Luna J. L. (1996) Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 88, 1576-1582.
53. Sjöberg M. and Vennström B. (1995) Ligand-dependent and -independent transactivation by thyroid hormone receptor β2 determined by the structure of the hormone response element. Mol. Cell. Biol. 15, 4718-4726.
54. Sonnenfeld M. J. and Jacobs J. R. (1995) Apoptosis of the midline glia during Drosophila embryogenesis: a correlation with axon contact. Development 121, 569-578.
55. Soriano E., del Río J. A., and Auladell C. (1993) Characterization of the phenotype and birthdates of pyknotic dead cells in the nervous system by a combination of DNA staining and immunohistochemistry for 5′-bromodeoxyuridine and neutral antigens. J. Histochem. Cytochem. 41, 819-827.
56. Tilly J. L. and Hsueh A. J. (1993) Microscale autoradiographic method for the qualitative and quantitative analysis of apoptotic DNA fragmentation. J. Cell. Physiol. 154, 519-526.
57. Toullec D., Pianetti P., Costé H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F., Duhamel L., Charon D., and Kirilovsky J. (1991) The bisindolylmaleimide GF109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 626, 15771-15781.
58. Weinberger C., Thompson C. C., Ong E. S., Lebo R., Gruol D. J., and Evans R. M. (1986) The c-erbA encodes a thyroid hormone receptor. Nature 324, 641-646.
59. Weller M., Malipiero U., Aguzzi A., Reed J. C., and Fontana A. (1995) Proto-oncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J. Clin. Invest. 95, 2633-2643.
60. Xia Z., Dickens M., Raingeaud J., Davis R. J., and Greenberg M. E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
61. Yen P. M. and Chin W. W. (1994) New advances in understanding the molecular mechanism of thyroid hormone action. Trends Endocrinol. Metab. 5, 65-72.